Skip to main content
Clinical Trials/ISRCTN14052478
ISRCTN14052478
Suspended
未知

Cognitive behaviour therapy for mental health problems in children with neurodevelopmental disorders: a transdiagnostic approach

York University0 sites100 target enrollmentMay 30, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
eurodevelopmental disorders (autism spectrum disorders, fetal alcohol spectrum disorder, cerebral palsy, learning disability, or attention deficit hyperactivity disorder)
Sponsor
York University
Enrollment
100
Status
Suspended
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 30, 2017
End Date
March 31, 2023
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 8\-13 years
  • 2\. Diagnosis of a neurodevelopmental disorder (autism spectrum disorder, fetal alcohol spectrum disorder, cerebral palsy, learning disability, or attention deficit hyperactivity disorder)
  • 3\. FSIQ \> 80 (WASI\-II; Weschler, 2011\)
  • 4\. At least one co\-occurring anxiety or mood disorder

Exclusion Criteria

  • 1\. Participants cannot be involved in another emotion regulation program within a 12\-month period of participating in SAS\-OR
  • 2\. Presence of a psychotic disorder, or aggressive/self\-injurious behaviours that pose a safety risk

Outcomes

Primary Outcomes

Not specified

Similar Trials